Published in Cancer on August 01, 1970
Malignant lymphomas of Waldeyer's ring: natural history and survival after radiotherapy. Br Med J (1972) 1.03
Staging laparotomy in non-Hodgkin's lymphomata. Br J Cancer Suppl (1975) 0.79
Prevalence of Common Non-Hodgkin Lymphomas and Subtypes of Hodgkin Lymphoma by Nodal Site of Involvement: A Systematic Retrospective Review of 938 Cases. Medicine (Baltimore) (2015) 0.77
Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med (1976) 9.68
Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med (1981) 7.53
Cancer in the elderly: why so badly treated? Lancet (1990) 3.67
Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial. Eur J Cancer (1990) 3.01
High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med (1997) 2.73
Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Cancer (1975) 2.52
Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med (1981) 2.50
Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans. J Clin Oncol (1995) 2.50
Local recurrences following mastectomy: support for the concept of tumor dormancy. J Natl Cancer Inst (1994) 2.34
The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance. Cancer (1977) 2.33
Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol (1996) 2.17
A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer. Ann Oncol (2005) 2.09
Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long-term results. Eur J Cancer Clin Oncol (1986) 2.05
Clinical evaluation of adriamycin, a new antitumour antibiotic. Br Med J (1969) 1.89
EORTC elderly task force position paper: approach to the older cancer patient. Eur J Cancer (2010) 1.80
Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled study. Ann Oncol (1998) 1.80
Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients. Cancer (1978) 1.75
Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials. Ann Oncol (2006) 1.74
Labeling index as a prognostic marker in non-Hodgkin's lymphomas. J Natl Cancer Inst (1981) 1.68
Patterns of second malignant neoplasms in children. Cancer (1977) 1.65
Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy. Breast Cancer Res Treat (1996) 1.61
Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD. J Clin Oncol (1997) 1.61
Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. J Clin Oncol (1987) 1.57
Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet (1989) 1.57
Determinants of career structure and advancement among Italian cardiologists. An example of segregation and discrimination against women? SCIC Group. Studio Condizione Italiana Cardiologi. Eur Heart J (1999) 1.56
Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer. Ann Oncol (1994) 1.54
Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. J Clin Oncol (1990) 1.53
Laparoscopy and laparotomy combined with bone marrow biopsy in staging Hodgkin's disease. Br Med J (1975) 1.52
Initial chemotherapy for primary resectable large-cell lymphoma of the stomach. Ann Oncol (1997) 1.51
Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer. Breast Cancer Res Treat (1985) 1.51
Phase I and preliminary phase II evaluation of adriamycin (NSC 123127). Cancer Res (1970) 1.50
Cardiac effects following adjuvant chemotherapy and breast irradiation in operable breast cancer. Ann Oncol (1994) 1.50
The trials of Dr. Bernard Fisher: a European perspective on an American episode. Control Clin Trials (1997) 1.49
Pharmacology and clinical toxicity of 4'-iodo-4'-deoxydoxorubicin: an example of successful application of pharmacokinetics to dose escalation in phase I trials. J Natl Cancer Inst (1990) 1.49
Are surgical adjuvant trials altering the course of breast cancer? Semin Oncol (1978) 1.49
Adjuvant chemotherapy of breast cancer. Br J Hosp Med (1980) 1.48
Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survival. Cancer J Sci Am (2006) 1.43
Proceedings: The value of staging laparotomy in non-Hodgkin's lymphomas (with emphasis on the histiocytic type). Cancer (1974) 1.43
Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease. Cancer J Sci Am (2000) 1.42
Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II study. Ann Oncol (2001) 1.41
Phase II evaluation of adriamycin in human neoplasia. Cancer (1973) 1.40
Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II study. J Clin Oncol (2000) 1.39
Older cancer patients in an Italian hospice. Ann Oncol (2009) 1.39
Epidemic Kaposi's sarcoma in Italy, a country with intravenous drug abusers as the major group at risk for AIDS: report of 60 cases. AIDS (1989) 1.38
Phase I-II intraperitoneal mitoxantrone in advanced pretreated ovarian cancer. Eur J Cancer (1993) 1.38
Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD. Eur J Cancer Clin Oncol (1985) 1.36
Salivary duct carcinoma: clinical characteristics and treatment strategies. Head Neck (1997) 1.33
Prognostic significance of lymphatic spread in head and neck carcinomas: therapeutic implications. Head Neck Surg (1986) 1.33
Natural history and survival of inoperable breast cancer treated with radiotherapy and radiotherapy followed by radical mastectomy. Cancer (1976) 1.32
Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer. Cancer (1975) 1.31
Does surgery modify growth kinetics of breast cancer micrometastases? Br J Cancer (2001) 1.31
Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. Ann Surg (1990) 1.28
Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process. Ann Oncol (2005) 1.27
The well-tempered vessel. Nat Med (2001) 1.27
Proposal for a new model of breast cancer metastatic development. Ann Oncol (1997) 1.26
Computer simulation of a breast cancer metastasis model. Breast Cancer Res Treat (1997) 1.26
Herpes zoster-varicella infection in malignant lymphomas. Influence of splenectomy and intensive treatment. Eur J Cancer (1975) 1.25
Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results. Ann Intern Med (1986) 1.24
Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood (1991) 1.23
Left atrial size is the major predictor of cardiac death and overall clinical outcome in patients with dilated cardiomyopathy: a long-term follow-up study. Clin Cardiol (1997) 1.23
Second acute leukemia and other malignancies following treatment for Hodgkin's disease. J Clin Oncol (1986) 1.23
Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer. Cancer Chemother Pharmacol (1978) 1.22
Adriamycin cardiotoxicity: a survey of 1273 patients. Cancer Treat Rep (1979) 1.22
Multimodal treatment in operable breast cancer: five-year results of the CMF programme. Br Med J (Clin Res Ed) (1981) 1.21
Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study. J Clin Oncol (1988) 1.21
Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper. Ann Oncol (2010) 1.20
Parametric survival analysis of adjuvant therapy for stage II breast cancer. Cancer (1994) 1.20
Lung cancer in the elderly. Eur J Cancer (1997) 1.19
Second malignancies in Hodgkin's disease: a complication of certain forms of treatment. Br Med J (1980) 1.19
Urinary hydroxyproline and calcium metabolism in patients with cancer. N Engl J Med (1966) 1.19
Preferential sites of involvement and spread in maignant lymphomas. Eur J Cancer (1968) 1.19
Cardiac toxicity of daunorubicin. Lancet (1969) 1.18
Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer. Breast Cancer Res Treat (1986) 1.18
Multimodal treatment for locally advanced breast cancer. Result of chemotherapy-radiotherapy versus chemotherapy-surgery. Cancer Clin Trials (1981) 1.17
Conservative treatment of breast cancer. A trial in progress at the Cancer Institute of Milan. Cancer (1977) 1.16
Response and survival in advanced breast cancer after two non-cross-resistant combinations. Br Med J (1976) 1.16
Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables. J Clin Oncol (2001) 1.15
Chemotherapy of breast cancer: current views and results. Int J Radiat Oncol Biol Phys (1983) 1.14
Primary malignant neoplasms associated with chronic lymphocytic leukemia. Tumori (1980) 1.14
Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes. J Clin Oncol (1991) 1.13
CT and chest radiography in the evaluation of adult respiratory distress syndrome. Acta Radiol (1994) 1.12
Alternating drug combinations in the treatment of advanced Hodgkin's disease. N Engl J Med (1982) 1.12
Chemotherapy in patients with recurrent and progressive central neurocytoma. Cancer (2000) 1.12
Current status of adjuvant chemotherapy for breast cancer. Semin Oncol (1987) 1.08
Three-dimensional sonographic diagnosis of ovarian pregnancy. Ultrasound Obstet Gynecol (2005) 1.08
Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease. Blood (1982) 1.07